Editorial

You have full text access to this OnlineOpen article

Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up†

  1. Ashokkumar Jain1,‡,*,
  2. Vrishali P. Patil1,
  3. John Fung2

Article first published online: 29 SEP 2008

DOI: 10.1002/lt.21609

Issue

Liver Transplantation

Liver Transplantation

Volume 14, Issue 10, pages 1406–1411, October 2008

Additional Information

How to Cite

Jain, A., Patil, V. P. and Fung, J. (2008), Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl, 14: 1406–1411. doi: 10.1002/lt.21609

Author Information

  1. 1

    Section of Solid Organ Transplantation, Department of Surgery, University of Rochester Medical Center, Rochester, NY

  2. 2

    Transplant Center, Department of General Surgery, Cleveland Clinic, Cleveland, OH

  1. ‡

    Telephone: 585-275-5875; FAX: 585-506-0054

*Section of Solid Organ Transplantation, Department of Surgery, University of Rochester Medical Center, 601 Elmwood Avenue, Box SURG, Rochester, NY 14642-8410

  1. †

    See Article on Page 1428

Publication History

  1. Issue published online: 29 SEP 2008
  2. Article first published online: 29 SEP 2008
  3. Manuscript Accepted: 3 JUL 2008
  4. Manuscript Received: 10 JUN 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (230K)

REFERENCES

  • 1
    Starzl T. Experience in Hepatic Transplantation. Philadelphia, PA: W.B. Saunders; 1969: 348.
  • 2
    McKhann CF. Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation 1969; 8: 209.
  • 3
    Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993; 12 (pt 2): S328.
  • 4
    Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969; 1: 106.
  • 5
    Matas AJ, Simmons RL, Najarian JS. Chronic antigenic stimulation, herpesvirus infection, and cancer in transplant recipients. Lancet 1975; 1: 1277.
  • 6
    Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972; 14: 407.
  • 7
    Gruber SA, Matas AJ. Etiology and pathogenesis of tumors occurring after organ transplantation. Transplant Sci 1994; 4: 87.
  • 8
    European FK 506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423.
  • 9
    Fung JJ, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Jordan M, et al. Overview of FK506 in transplantation. Clin Transpl 1990: 115.
  • 10
    Jain A, Demetris AJ, Kashyap R, Blakomer K, Ruppert K, Khan A, et al. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl 2001; 7: 623.
    Direct Link:
  • 11
    Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, et al. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation 2003; 75: 1020.
  • 12
    Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000; 232: 490.
  • 13
    Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001; 7(suppl 1): S109.
    Direct Link:
  • 14
    Jain A, Reyes J, Kashyap R, Rohal S, Abu-Elmagd K, Starzl T, Fung J. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg 1999; 230 : 441.
  • 15
    Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002; 8: 482.
    Direct Link:
  • 16
    Herrero JI, Lorenzo M, Quiroga J, Sangro B, Pardo F, Rotellar F, et al. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 2005; 11: 89.
    Direct Link:
  • 17
    Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant 2006; 20: 617.
    Direct Link:
  • 18
    Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 1998; 83: 1237.
    Direct Link:
  • 19
    Penn I. Primary malignancies of the hepato-biliary-pancreatic system in organ allograft recipients. J Hepatobiliary Pancreat Surg 1998; 5: 157.
  • 20
    Sheil AG. Malignancy following liver transplantation: a report from the Australian Combined Liver Transplant Registry. Transplant Proc 1995; 27: 1247.
  • 21
    Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, et al. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 1990; 212: 295.
  • 22
    Bessa X, Andreu H, Cirera I, Rimola A, Navasa M, Grande L et al. De novo tumors in adult patients with hepatic transplant [in Spanish]. Gastroenterol Hepatol 1997; 20: 442.
  • 23
    Catalina MV, de Diego A, García-Sánchez A, Escudero M, Salcedo M, Bañares R, Clemente G. Characterization of de novo malignancies in liver transplantation [in Spanish]. Gastroenterol Hepatol 2003; 26: 57.
  • 24
    Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34: 84.
  • 25
    Jaurrieta E, Casais L, Figueras J, Ramos E, Lama C, Rafecas A, et al. Analysis of 500 liver transplantations at Bellvitge Hospital, Spain [in Spanish]. Med Clin (Barc) 2000; 115: 521.
  • 26
    Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 80: 1141.
    Direct Link:
  • 27
    Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Gibbs J, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993; 25 (pt 2): 1397.
  • 28
    Peyrègne V, Ducerf C, Adham M, de la Roche E, Berthoux N, Bancel B, et al. De novo cancer after orthotopic liver transplantation. Transplant Proc 1998; 30: 1484.
  • 29
    Sanchez EQ, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002; 8: 285.
    Direct Link:
  • 30
    Xiol X, Guardiola J, Menendez S, Lama C, Figueras J, Marcoval J, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001; 7: 971.
    Direct Link:
  • 31
    Benlloch S, Berenguer M, Prieto M, Moreno R, San Juan F, Rayón M, et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004; 4: 596.
    Direct Link:
  • 32
    Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193.
  • 33
    Adami J, Gäbel H, Lindelöf B, Ekström K, Rydh B, Glimelius B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221.
  • 34
    Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681.
  • 35
    Vallejo GH, Romero CJ, de Vicente JC. Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol 2005; 56: 87.
  • 36
    Åberg F, Pukkala E, Höckerstedt K, Sankila R, Isoniemi H. Risk of malignant neoplasms after liver transplantation: a population based study. Liver Transpl 2008; 14: 1428–1436.
    Direct Link:
  • 37
    Jain A, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 2002; 236: 429.
  • 38
    Kenngott S, Gerbes AL, Schauer R, Bilzer M. Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis. Transpl Int 2003; 16: 639.
    Direct Link:
  • 39
    Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 1996; 2: 52.
    Direct Link:
  • 40
    Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung J. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 2000; 70: 1335.
  • 41
    Ehlers SL, Rodrigue JR, Widows MR, Reed AI, Nelson DR. Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research. Liver Transpl 2004; 10: 412.
    Direct Link:
  • 42
    DiMartini A, Day N, Dew MA, Lane T, Fitzgerald MG, Magill J, Jain A. Alcohol use following liver transplantation: a comparison of follow-up methods. Psychosomatics 2001; 42: 55.
  • 43
    Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW Jr, Doll R. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997; 337: 1705.
  • 44
    Jiménez C, Marqués E, Loinaz C, Romano DR, Gómez R, Meneu JC, et al. Upper aerodigestive tract and lung tumors after liver transplantation. Transplant Proc 2003; 35: 1900.
  • 45
    Bellamy CO, DiMartini AM, Ruppert K, Jain A, Dodson F, Torbenson M, et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001; 72: 619.
  • 46
    Berenguer M, Prieto M, Bustamante M, Carrasco D, López-Andújar R, Mir J, Berenguer J. Incidence of de novo neoplasms after liver transplantation [in Spanish]. Med Clin (Barc) 1998; 111: 481.
  • 47
    Safadi R, Ilan Y, Eid A, Galun E, Ashur Y, Goldin E, et al. Solid tumors after liver transplantation. Transplant Proc 1999; 31: 1894.
  • 48
    Schmilovitz-Weiss H, Mor E, Sulkes J, Bar-Nathan N, Shaharabani E, Melzer E, et al. De novo tumors after liver transplantation: a single-center experience. Transplant Proc 2003; 35: 665.
  • 49
    Trotter JF, Brazer SR. Rapid progression to high-grade dysplasia in Barrett's esophagus after liver transplantation. Liver Transpl Surg 1999; 5: 332.
    Direct Link:
  • 50
    Presser SJ, Schumacher G, Neuhaus R, Thuss-Patience P, Stieler J, Neuhaus P. De novo esophageal neoplasia after liver transplantation. Liver Transpl 2007; 13: 443.
    Direct Link:
  • 51
    Nagata Y, Eguchi S, Takatsuki M, Enjoji A, Ichikawa T, Hayashi T, Kanematsu T. Experience of gastric cancer in a patient who had received a living-donor liver transplantation. Gastric Cancer 2007; 10: 187.
  • 52
    Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003; 75: 1983.
  • 53
    Loftus EV Jr, Aguilar HI, Sandborn WJ, Tremaine WJ, Krom RA, Zinsmeister AR, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998; 27: 685.
    Direct Link:
  • 54
    Bleday R, Lee E, Jessurun J, Heine J, Wong WD. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36: 908.
  • 55
    Oruc MT, Soran A, Jain AK, Wilson JW, Fung J. De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature. Liver Transpl 2004; 10: 1.
    Direct Link:
  • 56
    Colditz GA, Stampfer MJ, Willett WC, Hennekens CH, Rosner B, Speizer FE. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 1990; 264: 2648.
View Full Article (HTML) Get PDF (230K)